PYPD
PolyPid Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$5.14
+2.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 19.38x
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $99.4M
- EV / sales
- —
- EV / EBITDA
- -3.23x
- EV / EBIT
- 85.41x
- Market cap
- $104.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026